Peng Hu

4.9k total citations
166 papers, 2.8k citations indexed

About

Peng Hu is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Peng Hu has authored 166 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Epidemiology, 77 papers in Hepatology and 34 papers in Molecular Biology. Recurrent topics in Peng Hu's work include Hepatitis B Virus Studies (77 papers), Hepatitis C virus research (61 papers) and Liver Disease Diagnosis and Treatment (57 papers). Peng Hu is often cited by papers focused on Hepatitis B Virus Studies (77 papers), Hepatitis C virus research (61 papers) and Liver Disease Diagnosis and Treatment (57 papers). Peng Hu collaborates with scholars based in China, United States and United Kingdom. Peng Hu's co-authors include Hong Ren, Huaidong Hu, Hu Li, Mingli Peng, Dazhi Zhang, Zhiwei Chen, Min Chen, Huaidong Hu, Yixuan Yang and Xing‐Hua Liao and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Peng Hu

153 papers receiving 2.7k citations

Peers

Peng Hu
Eiji Kakazu Japan
Sabine Mihm Germany
Keisuke Hamasaki Japan
Hong Tang China
Alison A. Evans United States
Pedro Majano Spain
Gadi Lalazar Israel
Nobuhiro Nakamoto Japan
Hirotoshi Ebinuma Japan
Eiji Kakazu Japan
Peng Hu
Citations per year, relative to Peng Hu Peng Hu (= 1×) peers Eiji Kakazu

Countries citing papers authored by Peng Hu

Since Specialization
Citations

This map shows the geographic impact of Peng Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Hu more than expected).

Fields of papers citing papers by Peng Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Hu. The network helps show where Peng Hu may publish in the future.

Co-authorship network of co-authors of Peng Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Hu. A scholar is included among the top collaborators of Peng Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Hu. Peng Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Chunrui, Hu Li, Zhiwei Chen, et al.. (2025). Unexpected HBsAg decrease after nucleoside analogues retreatment among HBeAg positive postpartum women: a pilot study. Virology Journal. 22(1). 36–36.
3.
Liang, Xieer, Qiaoqiao Chen, Hong Tang, et al.. (2025). Prevalence of Hepatitis D Virus Antibody Positivity in Chinese Patients with Chronic Hepatitis B Virus Infection. Journal of Clinical and Translational Hepatology. 0(0). 0–0.
4.
5.
Wu, Na, Zhiwei Chen, Wenhan Huang, et al.. (2024). Clinical and immunological features of COVID‐19 in patients with anti‐MDA5 dermatomyositis during the omicron wave in Chongqing, China. Journal of Medical Virology. 96(3). e29493–e29493. 1 indexed citations
6.
Hu, Peng, Cheng‐mei Tian, Kong Chen, et al.. (2024). Dissecting Innate and Adaptive Immunity in Inflammatory Bowel Disease: Immune Compartmentalization, Microbiota Crosstalk, and Emerging Therapies. Journal of Inflammation Research. Volume 17. 9987–10014. 4 indexed citations
7.
Hu, Peng, Xiaowen Peng, Shuang Zhao, et al.. (2024). Self-sacrificed construction of versatile nanoadjuvant for synergistically enhanced immunogenic cell death and improved anti-tumor immunity. Chemical Engineering Journal. 492. 152033–152033. 5 indexed citations
8.
9.
Xu, Hua, et al.. (2023). Function and autophagy of monocyte-derived dendritic cells is affected by hepatitis B virus infection. BMC Immunology. 24(1). 31–31. 2 indexed citations
10.
Shen, Wei, Hui Tang, Mingli Peng, et al.. (2022). KMCP: accurate metagenomic profiling of both prokaryotic and viral populations by pseudo-mapping. Bioinformatics. 39(1). 28 indexed citations
11.
Fan, Rong, Chao Qiu, Ruru Deng, et al.. (2022). [Expert consensus on measurement and clinical application of serum HBV RNA in patients with chronic HBV infection].. PubMed. 30(5). 505–512. 1 indexed citations
12.
Hu, Peng, Chao Xu, Rongzhi Liu, et al.. (2020). Comparison and application of different immunoassay methods for the detection of SARS‐CoV‐2. Journal of Medical Virology. 92(11). 2777–2784. 18 indexed citations
13.
B, Li, Weigan Shen, Peng Hu, et al.. (2019). Fibronectin 1 promotes melanoma proliferation and metastasis by inhibiting apoptosis and regulating EMT. SHILAP Revista de lepidopterología. 6 indexed citations
14.
15.
Hu, Peng & Hong Ren. (2016). [Current status of treatment of chronic hepatitis C and related challenges in the "Pre-DAA Era" in China].. PubMed. 24(11). 869–873. 5 indexed citations
16.
Chen, Zhiwei, Hu Li, Hong Ren, & Peng Hu. (2016). Global prevalence of pre-existing HCV variants resistant to direct-acting antiviral agents (DAAs): mining the GenBank HCV genome data. Scientific Reports. 6(1). 20310–20310. 76 indexed citations
17.
18.
Zhang, Yao, et al.. (2015). A comparison of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive patients: a prospective cohort study in China. Clinical Microbiology and Infection. 22(3). 287.e1–287.e9. 17 indexed citations
19.
Wang, Na, Huaidong Hu, Hang Sun, et al.. (2013). Comparison of the forty-eight week efficacy between telbivudine and entecavir in HBeAgpositive Asian patients with chronic hepatitis B: A meta-analysis. The Turkish Journal of Gastroenterology. 24(3). 230–240. 4 indexed citations
20.
Hu, Peng, John R. Moffett, Jason Myers, et al.. (2001). Novel Nuclear Signaling Pathway Mediates Activation of Fibroblast Growth Factor-2 Gene by Type 1 and Type 2 Angiotensin II Receptors. Molecular Biology of the Cell. 12(2). 449–462. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eiji Kakazu Breakdown of academic impact, for papers by Sabine Mihm Breakdown of academic impact, for papers by Keisuke Hamasaki Breakdown of academic impact, for papers by Hong Tang Breakdown of academic impact, for papers by Alison A. Evans Breakdown of academic impact, for papers by Pedro Majano Breakdown of academic impact, for papers by Gadi Lalazar Breakdown of academic impact, for papers by Nobuhiro Nakamoto Breakdown of academic impact, for papers by Hirotoshi Ebinuma
Rankless by CCL
2026